Anti-Human NF Kappa B Inhibitor alpha (C-Terminal) Antibody (Serum)
Rabbit Anti-Human Polyclonal Antibody
|Application ||WB, IHC-F, E, IP|
|Calculated MW||35609 Da|
|Immunogen||NFkBIa peptide corresponding to a region near the C-terminus of the human protein, conjugated with KLH.|
|Shelf Life||18 months from date of despatch.|
|Other Names||NF-kappa-B inhibitor alpha, I-kappa-B-alpha, IkB-alpha, IkappaBalpha, Major histocompatibility complex enhancer-binding protein MAD3, NFKBIA, IKBA, MAD3, NFKBI|
|Target/Specificity||ABD10805 is specific for NF-kappa-B inhibitor alpha (also known as IkB alpha), one of seven members of the IkB class of inhibitor proteins that have been identified to date. NFkBIa inhibits the NFkB complex in unstimulated cells through non-covalent binding. Following stimulation of cells, IkB alpha is phosphorylated so that it dissociates from the NFkB, and then ubiquinated prior to degradation.|
|Preservative & Stabilisers||0.09% Sodium Azide|
|Storage||Store at +4℃ or at -20 ℃.|
|Precautions||Anti-Human NF Kappa B Inhibitor alpha (C-Terminal) Antibody (Serum) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Hoffmann, A et al. (2002) The IkappaB-NK-kappaB signalling module.Temporal control and selective gene activation.Science.298.1241-1245
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.